Citations (109)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens, Serge Muyldermans, Karine Breckpot, Frank Bruchertseifer, Alfred Morgenstern, Matthias D’Huyvetter & Nick Devoogdt. (2021) CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma. OncoImmunology 10:1.
Read now
Read now
Articles from other publishers (108)
Samantha Gogola, Michael Rejzer & Robert Poppiti. 2024. Therapy Resistance in Prostate Cancer. Therapy Resistance in Prostate Cancer
255
287
.
Yana Dekempeneer, Sam Massa, Francis Santens, Laurent Navarro, Marion Berdal, Melissa Miranda Lucero, Ana Rita Pombo Antunes, Tony Lahoutte, Jo A. Van Ginderachter, Nick Devoogdt & Matthias D’Huyvetter. (2023) Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α. Journal of Nuclear Medicine 64:12, pages 1941-1948.
Crossref
Crossref
K. Sugihara, S. Meigo, H. Iwamoto & F. Maekawa. (2023)
Measurement of nuclide production cross sections for proton-induced reactions on
Ti and 93Nb at 0.8 and 3.0 GeV
. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 545, pages 165153.
Crossref
Crossref
Sena Hamagami, Shunsuke Fujino & Takahiro Yamada. (2023) Performance evaluation of alpha-particle discrimination using ultra-thin plastic scintillation sheets and their application to alpha-emitters for targeted alpha therapy. Applied Radiation and Isotopes 202, pages 111036.
Crossref
Crossref
Matthijs Bart C. Sevenois, Brian WM. Miller, Holger Jan Jensen, Matthias D'Huyvetter & Peter Covens. (2023) Optimized cyclotron production of 211At: The challenge of 210Po-characterization. Radiation Physics and Chemistry 212, pages 111155.
Crossref
Crossref
Csaba Csikos, Zita Képes, Anikó Fekete, Adrienn Vágner, Gábor Nagy, Barbara Gyuricza, Viktória Arató, Levente Kárpáti, István Mándity, Frank Bruchertseifer, Gábor Halmos, Dezső Szikra & György Trencsényi. (2023) Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model. International Journal of Pharmaceutics 644, pages 123344.
Crossref
Crossref
Kenji Makita, Yasushi Hamamoto, Hiromitsu Kanzaki, Natsumi Yamashita, Kei Nagasaki, Teruhito Kido, Noriyoshi Miura, Takashi Saika & Katsuyoshi Hashine. (2023) Impact of timing of radium‑223 administration on the survival of patients with bone metastatic castration‑resistant prostate cancer. Medicine International 3:4.
Crossref
Crossref
Kate Hurley, Meiyun Cao, Haiming Huang & Yi Wang. (2023) Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies). Cancers 15:13, pages 3493.
Crossref
Crossref
Zita Képes, István Hajdu, Ferenc Fenyvesi & György Trencsényi. (2023) Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: Towards a novel oncological era. International Journal of Pharmaceutics 640, pages 122978.
Crossref
Crossref
Ibolya Kálmán-Szabó, Zita Képes, Anikó Fekete, Adrienn Vágner, Gábor Nagy, Dániel Szücs, Barbara Gyuricza, Viktória Arató, József Varga, Levente Kárpáti, Ildikó Garai, István Mándity, Frank Bruchertseifer, János Elek, Dezs Szikra & György Trencsényi. (2023) In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model. Journal of Pharmaceutical and Biomedical Analysis 229, pages 115374.
Crossref
Crossref
Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt, Timo W. M. De Groof, Dora Mugoli Chigoho, Parinaz Asiabi, Peter Covens, Matthias D’Huyvetter & Nick Devoogdt. (2023) Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy. Pharmaceutics 15:5, pages 1378.
Crossref
Crossref
Sara Vosoughi, Nafise Salek, Hassan Yousefnia, Milad Delavari, Seyed Mahmoud Reza Aghamiri & Hassan Ranjbar. (2023) Estimation of Human Absorbed Dose of
188Re-Hynic-Bombesin Based on
Biodistribution Data in Rats. Current Radiopharmaceuticals 16:1, pages 64-70.
Crossref
Crossref
Soghra Farzipour, Zahra Shaghaghi, Marziyeh Raeispour, Maryam Alvandi, Fatemeh Jalali & Amirhossein Yazdi. (2023) Evaluation of the Effect of Chelating Arms and Carrier Agents on t he
Radiotoxicity of TAT Agents. Current Radiopharmaceuticals 16:1, pages 2-22.
Crossref
Crossref
Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan & Michael R. Zalutsky. (2023)
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose
211
At-Labeled Anti-HER2 Single-Domain Antibody Fragment
. Journal of Nuclear Medicine 64:1, pages 124-130.
Crossref
Crossref
Laura Lopez-Odriozola, Lauren Walker & Louise S. Natrajan. 2023. Comprehensive Inorganic Chemistry III. Comprehensive Inorganic Chemistry III
789
807
.
Cyprine Neba Funeh, Parinaz Asiabi, Matthias D’Huyvetter & Nick Devoogdt. 2023. Radiopharmaceutical Therapy. Radiopharmaceutical Therapy
253
273
.
Axel Berg-Larsen, Anne Mobergslien, Ingrid Moen, Gebregziabher Petros, Alexander Kristian, Kristine Sponheim Gunvaldsen, Véronique Cruciani, Katrine Wickstroem, Roger Malerbakken Bjerke, Jenny Karlsson & Alan Cuthbertson. (2022) Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model. Frontiers in Medicine 9.
Crossref
Crossref
Xiang Cheng, Fanfan Li & Lizhen Liang. (2022) Boron Neutron Capture Therapy: Clinical Application and Research Progress. Current Oncology 29:10, pages 7868-7886.
Crossref
Crossref
Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W. Miller, Matthijs B. Sevenois, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, Matthias D'Huyvetter & Marek Pruszynski. (2022) Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer. Molecular Cancer Therapeutics.
Crossref
Crossref
Mohammad R Alam, Shashi B Singh, Shreeya Thapaliya, Shreeya Shrestha, Sulav Deo & Kishor Khanal. (2022) A Review of 177Lutetium-PSMA and 225Actinium-PSMA as Emerging Theranostic Agents in Prostate Cancer. Cureus.
Crossref
Crossref
Jonathan D. Burns, Evgeny E. Tereshatov, Bowen Zhang, Gabriel C. Tabacaru, Lauren A. McIntosh, Steven J. Schultz, Laura A. McCann, Bryan M. Harvey, Andrew Hannaman, Kylie N. Lofton, Maxwell Q. Sorensen, Amy L. Vonder Haar, Michael B. Hall & Sherry J. Yennello. (2022)
Complexation of Astatine(III) with Ketones: Roles of NO
3
–
Counterion and Exploration of Possible Binding Modes
. Inorganic Chemistry 61:31, pages 12087-12096.
Crossref
Crossref
Jo Caers, Elodie Duray, Louise Vrancken, Guillaume Marcion, Valentina Bocuzzi, Kim De Veirman, Ahmet Krasniqi, Margaux Lejeune, Nadia Withofs, Nick Devoogdt, Mireille Dumoulin, Amelie Eriksson Karlström & Matthias D’Huyvetter. (2022) Radiotheranostic Agents in Hematological Malignancies. Frontiers in Immunology 13.
Crossref
Crossref
Aiying Xue & Saijun Fan. (2022) Matrices and Affinity Ligands for Antibody Purification and Corresponding Applications in Radiotherapy. Biomolecules 12:6, pages 821.
Crossref
Crossref
Stephen Tronchin, Jake C Forster, Kevin Hickson & Eva Bezak. (2022) Dosimetry in targeted alpha therapy. A systematic review: current findings and what is needed. Physics in Medicine & Biology 67:9, pages 09TR01.
Crossref
Crossref
Soghra Farzipour, Zahra Shaghaghi, Sahar Abbasi, Hajar Albooyeh & Maryam Alvandi. (2022) Recent Achievements about Targeted Alpha Therapy-Based Targeting Vectors and Chelating Agents. Anti-Cancer Agents in Medicinal Chemistry 22:8, pages 1496-1510.
Crossref
Crossref
Asaad H. Ismail & Runas Y. Sola. (2022) Fabrication of alpha irradiation technique and study the impact of low alpha particles density on the lymphoblast cells of Leukemia blood samples. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 1031, pages 166494.
Crossref
Crossref
Bárbara Nayane Rosário Fernandes Souza, Elisabete Regina Fernandes Ramos Ribeiro, Aline Oliveira da Silva de Barros, Martha Sahylí Ortega Pijeira, Hericka Oliveira Kenup-Hernandes, Eduardo Ricci-Junior, Joel Félix Silva Diniz Filho, Clenilton Costa dos Santos, Luciana Magalhães Rebelo Alencar, Mohamed F. Attia, Sara Gemini-Piperni & Ralph Santos-Oliveira. (2022) Nanomicelles of Radium Dichloride [223Ra]RaCl2 Co-Loaded with Radioactive Gold [198Au]Au Nanoparticles for Targeted Alpha–Beta Radionuclide Therapy of Osteosarcoma. Polymers 14:7, pages 1405.
Crossref
Crossref
Kazuaki Baba, Kojiro Nagata, Tatsuo Yajima & Takashi Yoshimura. (2022) Synthesis, Structures, and Equilibrium Reactions of La(III) and Ba(II) Complexes with Pyridine Phosphonate Pendant Arms on a Diaza-18-crown-6 Ether. Bulletin of the Chemical Society of Japan 95:3, pages 466-475.
Crossref
Crossref
Michael K. Schultz, Jean-Pierre Pouget, Frank Wuest, Bryce Nelson, Jan Andersson, Sarah Cheal, Mengshi Li, Fiorenza Ianzini, Sangeeta Ray, Stephen A. Graves & Nicolas Chouin. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
380
403
.
Meltem Ocak. 2022. Radionuclide Therapy. Radionuclide Therapy
3
17
.
Fangling Ji, Jun Ren, Cécile Vincke, Lingyun Jia & Serge Muyldermans. 2022. Single-Domain Antibodies. Single-Domain Antibodies
3
17
.
Guangfa Bao, Ming Tang, Jun Zhao & Xiaohua Zhu. (2021) Nanobody: a promising toolkit for molecular imaging and disease therapy. EJNMMI Research 11:1.
Crossref
Crossref
Ahmet Kaynak, Harold W. Davis, Subrahmanya D. Vallabhapurapu, Koon Y. Pak, Brian D. Gray & Xiaoyang Qi. (2021) SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. Pharmaceuticals 14:11, pages 1193.
Crossref
Crossref
Andrea Cimini, Maria Ricci, Francesca Russo, Martina Egidi, Ferdinando Calabria, Antonio Bagnato, Orazio Schillaci & Agostino Chiaravalloti. (2021) Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview. Pharmaceuticals 14:9, pages 872.
Crossref
Crossref
Hanbo Zhang, Stella Koumna, Frédéric Pouliot, Jean-Mathieu Beauregard & Michael Kolinsky. (2021) PSMA Theranostics: Current Landscape and Future Outlook. Cancers 13:16, pages 4023.
Crossref
Crossref
Maydelid Trujillo-Nolasco, Enrique Morales-Avila, Pedro Cruz-Nova, Kattesh Katti & Blanca Ocampo-García. (2021) Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications. Pharmaceutics 13:8, pages 1123.
Crossref
Crossref
Noha Anwer Bayoumi & Mohamed Taha El-Kolaly. (2021) Utilization of nanotechnology in targeted radionuclide cancer therapy: monotherapy, combined therapy and radiosensitization. Radiochimica Acta 109:6, pages 459-475.
Crossref
Crossref
David J. Fiszbein, Victoria Brown, Nikki A. Thiele, Joshua J. Woods, Luke Wharton, Samantha N. MacMillan, Valery Radchenko, Caterina F. Ramogida & Justin J. Wilson. (2021)
Tuning the Kinetic Inertness of Bi
3+
Complexes: The Impact of Donor Atoms on Diaza-18-Crown-6 Ligands as Chelators for
213
Bi Targeted Alpha Therapy
. Inorganic Chemistry 60:12, pages 9199-9211.
Crossref
Crossref
Shino Manabe, Hiroki Takashima, Kazunobu Ohnuki, Yoshikatsu Koga, Ryo Tsumura, Nozomi Iwata, Yang Wang, Takuya Yokokita, Yukiko Komori, Sachiko Usuda, Daiki Mori, Hiromitsu Haba, Hirofumi Fujii, Masahiro Yasunaga & Yasuhiro Matsumura. (2021)
Stabilization of an
211
At-Labeled Antibody with Sodium Ascorbate
. ACS Omega 6:23, pages 14887-14895.
Crossref
Crossref
Fouad A. Abolaban, Essam M. Banoqitah, Eslam M. Taha, Abdulsalam M. Alhawsawi, Fathi A. Djouider & Andrew Nisbet. (2021) Production of actinium-225 from a (n,p) reaction: Feasibility and pre-design studies. Nukleonika 66:2, pages 61-67.
Crossref
Crossref
Stephen Ahenkorah, Irwin Cassells, Christophe M. Deroose, Thomas Cardinaels, Andrew R. Burgoyne, Guy Bormans, Maarten Ooms & Frederik Cleeren. (2021) Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside. Pharmaceutics 13:5, pages 599.
Crossref
Crossref
Majid Piramoon, Fatemeh Khodadust & Seyed Jalal Hosseinimehr. (2021) Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:2, pages 188529.
Crossref
Crossref
Imma Carbo‐Bague & Caterina F. Ramogida. 2012. Encyclopedia of Inorganic and Bioinorganic Chemistry. Encyclopedia of Inorganic and Bioinorganic Chemistry
1
34
.
Diane S. Abou, Nikki A. Thiele, Nicholas T. Gutsche, Alexandria Villmer, Hanwen Zhang, Joshua J. Woods, Kwamena E. Baidoo, Freddy E. Escorcia, Justin J. Wilson & Daniel L. J. Thorek. (2021) Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand. Chemical Science 12:10, pages 3733-3742.
Crossref
Crossref
Desiree Erika Fiaccabrino, Peter Kunz & Valery Radchenko. (2021) Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb. Nuclear Medicine and Biology 94-95, pages 81-91.
Crossref
Crossref
Weihao Liu, Yu Tang, Huan Ma, Feize Li, Yingjiang Hu, Yuanyou Yang, Jijun Yang, Jiali Liao & Ning Liu. (2021)
Astatine-211 labelled a small molecule peptide: specific cell killing
in vitro
and targeted therapy in a nude-mouse model
. Radiochimica Acta 109:2, pages 119-126.
Crossref
Crossref
Jonathan D. Burns, Evgeny E. Tereshatov, Geoffrey Avila, Kevin J. Glennon, Andrew Hannaman, Kylie N. Lofton, Laura A. McCann, Mallory A. McCarthy, Lauren A. McIntosh, Steven J. Schultz, Gabriel C. Tabacaru, Amy L. Vonder Haar & Sherry J. Yennello. (2021) Rapid recovery of At-211 by extraction chromatography. Separation and Purification Technology 256, pages 117794.
Crossref
Crossref
Brian Geist, Songmao Zheng & Yan Xu. 2021. Remington. Remington
437
462
.
Xudong Wang, Wenzong Ma, Weihao Liu, Huan Ma, Yuanyou Yang, Yugang Wang, Ning Liu & Gen Yang. (2020) Construction and Preclinical Evaluation of 211At Labeled Anti-mesothelin Antibodies as Potential Targeted Alpha Therapy Drugs. Journal of Radiation Research 61:5, pages 684-690.
Crossref
Crossref
Yana Dekempeneer, Vicky Caveliers, Maarten Ooms, Dominic Maertens, Mireille Gysemans, Tony Lahoutte, Catarina Xavier, Quentin Lecocq, Ken Maes, Peter Covens, Brian W. Miller, Frank Bruchertseifer, Alfred Morgenstern, Thomas Cardinaels & Matthias D’Huyvetter. (2020)
Therapeutic Efficacy of
213
Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer
. Molecular Pharmaceutics 17:9, pages 3553-3566.
Crossref
Crossref
Urs B. HagemannKatrine WickstroemStefanie HammerRoger M. BjerkeSabine Zitzmann-KolbeOlav B. RyanJenny KarlssonArne ScholzHartwig HennekesDominik MumbergAlan S. Cuthbertson. (2020) Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy. Cancer Biotherapy and Radiopharmaceuticals 35:7, pages 497-510.
Crossref
Crossref
Harold W. Davis, Subrahmanya D. Vallabhapurapu, Zhengtao Chu, Michael A. Wyder, Kenneth D. Greis, Venette Fannin, Ying Sun, Pankaj B. Desai, Koon Y. Pak, Brian D. Gray & Xiaoyang Qi. (2020) Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles. Cells 9:9, pages 1960.
Crossref
Crossref
Francisco D.C. Guerra LiberalJoe M. O'SullivanStephen J. McMahonKevin M. Prise. (2020) Targeted Alpha Therapy: Current Clinical Applications. Cancer Biotherapy and Radiopharmaceuticals 35:6, pages 404-417.
Crossref
Crossref
Mine Silindir-GunayMerve KarpuzA. Yekta Ozer. (2020) Targeted Alpha Therapy and Nanocarrier Approach. Cancer Biotherapy and Radiopharmaceuticals 35:6, pages 446-458.
Crossref
Crossref
Daphnée Villoing, Thomas A Cuthbert, Cari M Kitahara & Choonsik Lee. (2020) NCINM: organ dose calculator for patients undergoing nuclear medicine procedures. Biomedical Physics & Engineering Express 6:5, pages 055010.
Crossref
Crossref
Benjamin B. Kasten, Soldano Ferrone, Kurt R. Zinn & Donald J. Buchsbaum. (2020) B7-H3-targeted Radioimmunotherapy of Human Cancer. Current Medicinal Chemistry 27:24, pages 4016-4038.
Crossref
Crossref
Neil MacRitchie, Marina Frleta-Gilchrist, Atsuko Sugiyama, Tristan Lawton, Iain B. McInnes & Pasquale Maffia. (2020) Molecular imaging of inflammation - Current and emerging technologies for diagnosis and treatment. Pharmacology & Therapeutics 211, pages 107550.
Crossref
Crossref
Mai LinRobert T. TaKalevi KairemoDao B. LeGregory C. Ravizzini. (2020) Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals in Diagnosis and Therapy of Prostate Cancer: Current Status and Future Perspectives. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Crossref
Xudong Wang, Feng Wang, Jintao Han, Zhi Yang, Hua Zhu & Gen Yang. (2020)
Construction and Preclinical Evaluation of a
124/131
I-Labeled Radiotracer for the Detection of Mesothelin-Overexpressing Cancer
. Molecular Pharmaceutics 17:6, pages 1875-1883.
Crossref
Crossref
B.E. Ellerin, C.G.N. Demandante & J.T. Martins. (2020) Pure abscopal effect of radiotherapy in a salivary gland carcinoma: Case report, literature review, and a search for new approaches. Cancer/Radiothérapie 24:3, pages 226-246.
Crossref
Crossref
Martina Sollini, Katia Marzo, Arturo Chiti & Margarita Kirienko. (2020) The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How?. Rendiconti Lincei. Scienze Fisiche e Naturali 31:2, pages 231-247.
Crossref
Crossref
K. Sugihara, N. Shigyo, E. Lee, T. Sanami & K. Tanaka. (2020)
Measurement of thick target neutron yields from 7 MeV/u
incidence on 209Bi
. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 470, pages 15-20.
Crossref
Crossref
Janik Puttemans, Yana Dekempeneer, Jos L. Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Albert D. Windhorst, Frank van der Aa, Quentin Lecocq, Karine Breckpot, Alfred Morgenstern, Frank Bruchertseifer, Tony Lahoutte, Nick Devoogdt & Matthias D’Huyvetter. (2020) Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies. Cancers 12:4, pages 1017.
Crossref
Crossref
Malwina Czerwińska, Aleksander Bilewicz, Marcin Kruszewski, Aneta Wegierek-Ciuk & Anna Lankoff. (2020) Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives. Molecules 25:7, pages 1743.
Crossref
Crossref
A. K. M. Rezaur Rahman & Abdul Awal. (2019) Production of 149Tb, 152Tb, 155Tb and 161Tb from gadolinium using different light-particle beams. Journal of Radioanalytical and Nuclear Chemistry 323:2, pages 731-740.
Crossref
Crossref
Pieterjan Debie, Chrystel Lafont, Michel Defrise, Inge Hansen, Danny M. van Willigen, Fijs W.B. van Leeuwen, Rik Gijsbers, Matthias D'Huyvetter, Nick Devoogdt, Tony Lahoutte, Patrice Mollard & Sophie Hernot. (2020) Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours. Journal of Controlled Release 317, pages 34-42.
Crossref
Crossref
Kristina Bannik, Balázs Madas, Marco Jarzombek, Andreas Sutter, Gerhard Siemeister, Dominik Mumberg & Sabine Zitzmann-Kolbe. (2019) Radiobiological effects of the alpha emitter Ra-223 on tumor cells. Scientific Reports 9:1.
Crossref
Crossref
Maryline G. Ferrier & Valery Radchenko. (2019) An Appendix of Radionuclides Used in Targeted Alpha Therapy. Journal of Medical Imaging and Radiation Sciences 50:4, pages S58-S65.
Crossref
Crossref
G. De Vincentis, W. Gerritsen, J.E. Gschwend, M. Hacker, V. Lewington, J.M. O’Sullivan, M. Oya, M. Pacilio, C. Parker, N. Shore & O. Sartor. (2019) Advances in targeted alpha therapy for prostate cancer. Annals of Oncology 30:11, pages 1728-1739.
Crossref
Crossref
Maryline G. Ferrier, Valery Radchenko & D. Scott Wilbur. (2019) Radiochemical aspects of alpha emitting radionuclides for medical application. Radiochimica Acta 107:9-11, pages 1065-1085.
Crossref
Crossref
Roobol, Kouwenberg, Denkova, Kanaar & Essers. (2019) Large Field Alpha Irradiation Setup for Radiobiological Experiments. Methods and Protocols 2:3, pages 75.
Crossref
Crossref
Nikki A. Thiele, Joshua J. Woods & Justin J. Wilson. (2019) Implementing f-Block Metal Ions in Medicine: Tuning the Size Selectivity of Expanded Macrocycles. Inorganic Chemistry 58:16, pages 10483-10500.
Crossref
Crossref
Mari I. Suominen, Timothy Wilson, Sanna-Maria Käkönen & Arne Scholz. (2019) The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis. International Journal of Molecular Sciences 20:16, pages 3899.
Crossref
Crossref
Yana Dekempeneer, Tom Bäck, Emma Aneheim, Holger Jensen, Janik Puttemans, Catarina Xavier, Marleen Keyaerts, Stig Palm, Per Albertsson, Tony Lahoutte, Vicky Caveliers, Sture Lindegren & Matthias D’Huyvetter. (2019) Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior. Molecular Pharmaceutics 16:8, pages 3524-3533.
Crossref
Crossref
Puttemans, Lahoutte, D’Huyvetter & Devoogdt. (2019) Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases. Pharmaceutics 11:8, pages 376.
Crossref
Crossref
Urs B. Hagemann, Christine Ellingsen, Joachim Schuhmacher, Alexander Kristian, Anne Mobergslien, Véronique Cruciani, Katrine Wickstroem, Christoph A. Schatz, Christoph Kneip, Sven Golfier, Roger Smeets, Steinar Uran, Hartwig Hennekes, Jenny Karlsson, Roger M. Bjerke, Olav B. Ryan, Dominik Mumberg, Karl Ziegelbauer & Alan S. Cuthbertson. (2019) Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers. Clinical Cancer Research 25:15, pages 4723-4734.
Crossref
Crossref
Zhen Liu & Xiaoli Lan. (2019) Microfluidic radiobioassays: a radiometric detection tool for understanding cellular physiology and pharmacokinetics. Lab on a Chip 19:14, pages 2315-2339.
Crossref
Crossref
Clemens Kratochwil, Uwe Haberkorn & Frederik L. Giesel. (2019) Radionuclide Therapy of Metastatic Prostate Cancer. Seminars in Nuclear Medicine 49:4, pages 313-325.
Crossref
Crossref
Christoph Denk, Martin Wilkovitsch, Emma Aneheim, Matthias M. Herth, Holger Jensen, Sture Lindegren & Hannes Mikula. (2019) Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio‐Crosslinking. ChemPlusChem 84:7, pages 775-778.
Crossref
Crossref
Jongho Jeon. (2019) Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials. International Journal of Molecular Sciences 20:9, pages 2323.
Crossref
Crossref
Samuel M. Wiggins, Marie Boyd, Enrico Brunetti, Nick M. H. Butler, James S. Feehan, Ross J. Gray, Bernhard Hidding, David G. Ireland, Wentao Li, Antoine Maitrallain, Grace G. Manahan, Paul McKenna, David O'Donnell, Marcus Scheck, Mohammed Shahzad, Zheng-Ming Sheng, Roman Spesyvtsev, Gregory Vieux, Daniel P. Watts, Gregor H. Welsh, Robbie Wilson, Nicholas Zachariou & Dino A. Jaroszynski. (2019) Application programmes at the Scottish Centre for the Application of Plasma-based Accelerators (SCAPA). Application programmes at the Scottish Centre for the Application of Plasma-based Accelerators (SCAPA).
Kazuma Ogawa, Takuya Takeda, Kenji Mishiro, Atsushi Toyoshima, Kazuhiro Shiba, Takashi Yoshimura, Atsushi Shinohara, Seigo Kinuya & Akira Odani. (2019) Radiotheranostics Coupled between an At-211-Labeled RGD Peptide and the Corresponding Radioiodine-Labeled RGD Peptide. ACS Omega 4:3, pages 4584-4591.
Crossref
Crossref
Wenzong Ma, Xudong Wang, Weihao Liu, Huan Ma, Yue Su, Yuanyou Yang, Ning Liu, Yugang Wang & Gen Yang. (2019) A Theoretical Model for Predicting and Optimizing In Vitro Screening of Potential Targeted Alpha-Particle Therapy Drugs. Radiation Research 191:5, pages 475.
Crossref
Crossref
Javian Malcolm, Nadia Falzone, Boon Lee & Katherine Vallis. (2019) Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response. Cancers 11:2, pages 268.
Crossref
Crossref
Pieterjan Debie, Nick Devoogdt & Sophie Hernot. (2019) Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery. Antibodies 8:1, pages 12.
Crossref
Crossref
D. DzhuzhaProf.Prof. & S. MyasoyedovProf.Prof.. (2019) Radionuclide therapy with alpha-emitters. Radiation Diagnostics, Radiation Therapy:4, pages 37-47.
Crossref
Crossref
B. L. Garashchenko, V. A. Korsakova & R. Yu. Yakovlev. (2019) Radiopharmaceuticals Based on Alpha Emitters: Preparation, Properties, and Application. Physics of Atomic Nuclei 81:10, pages 1515-1525.
Crossref
Crossref
I Kambali. (2018) Calculated astatine-211 production yields for radioimmunotherapy. Journal of Physics: Conference Series 1116, pages 032013.
Crossref
Crossref
H. Ghaffari, J. Beik, A. Talebi, S. R. Mahdavi & H. Abdollahi. (2018) New physical approaches to treat cancer stem cells: a review. Clinical and Translational Oncology 20:12, pages 1502-1521.
Crossref
Crossref
Christopher Parker, Valerie Lewington, Neal Shore, Clemens Kratochwil, Moshe Levy, Ola Lindén, Walter Noordzij, Jae Park & Fred Saad. (2018) Targeted Alpha Therapy, an Emerging Class of Cancer Agents. JAMA Oncology 4:12, pages 1765.
Crossref
Crossref
Mark A. Moore, Robert M. Counce, Jack S. Watson & Howard Hall. (2018) The Performance of two silica based ion exchange resins in the separation of 213Bi from its parent solution of 225Ac. Applied Radiation and Isotopes 141, pages 68-72.
Crossref
Crossref
Nikki A. ThieleJustin J. Wilson. (2018) Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches. Cancer Biotherapy and Radiopharmaceuticals 33:8, pages 336-348.
Crossref
Crossref
Bas M. Bavelaar, Boon Q. Lee, Martin R. Gill, Nadia Falzone & Katherine A. Vallis. (2018) Subcellular Targeting of Theranostic Radionuclides. Frontiers in Pharmacology 9.
Crossref
Crossref
Dongyoul Lee, Mengshi Li, Bryan Bednarz & Michael K. Schultz. (2018) Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy. Radiation Research 190:3, pages 236.
Crossref
Crossref
Eva R. Birnbaum, Michael E. Fassbender, Maryline G. Ferrier, Kevin D. John & Tara Mastren. 2012. Encyclopedia of Inorganic and Bioinorganic Chemistry. Encyclopedia of Inorganic and Bioinorganic Chemistry
1
21
.
Diane E. MilenicYoung-Seung KimKwamena E. BaidooKaren J. WongRachel BarkleyJose DelgadoMartin W. Brechbiel. (2018)
Exploration of a F(ab′)
2
Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy
. Cancer Biotherapy and Radiopharmaceuticals 33:5, pages 182-193.
Crossref
Crossref
Ján Kozempel, Olga Mokhodoeva & Martin Vlk. (2018) Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators. Molecules 23:3, pages 581.
Crossref
Crossref
María Elena Iezzi, Lucía Policastro, Santiago Werbajh, Osvaldo Podhajcer & Gabriela Alicia Canziani. (2018) Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment. Frontiers in Immunology 9.
Crossref
Crossref
Nobuaki Matsubara, Satsohi Nagamori, Yoshiaki Wakumoto, Hirotsugu Uemura, Go Kimura, Akira Yokomizo, Hiroaki Kikukawa, Atsushi Mizokami, Takeo Kosaka, Naoya Masumori, Yoshihide Kawasaki, Junji Yonese, Yasutomo Nasu, Satoshi Fukasawa, Takayuki Sugiyama, Seigo Kinuya, Makoto Hosono, Iku Yamaguchi, Hirokazu Tsutsui & Hiroji Uemura. (2017) Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer. International Journal of Clinical Oncology 23:1, pages 173-180.
Crossref
Crossref
Fable Zustovich & Roberto Barsanti. (2017) Targeted α Therapies for the Treatment of Bone Metastases. International Journal of Molecular Sciences 19:1, pages 74.
Crossref
Crossref
Grégory Thiabaud, Valery Radchenko, Justin J. Wilson, Kevin D. John, Eva R. Birnbaum & Jonathan L. Sessler. (2017) Rapid insertion of bismuth radioactive isotopes into texaphyrin in aqueous media. Journal of Porphyrins and Phthalocyanines 21:12, pages 882-886.
Crossref
Crossref
Peter Bannas, Julia Hambach & Friedrich Koch-Nolte. (2017) Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics. Frontiers in Immunology 8.
Crossref
Crossref
Nikki A. Thiele, Victoria Brown, James M. Kelly, Alejandro Amor‐Coarasa, Una Jermilova, Samantha N. MacMillan, Anastasia Nikolopoulou, Shashikanth Ponnala, Caterina F. Ramogida, Andrew K. H. Robertson, Cristina Rodríguez‐Rodríguez, Paul Schaffer, Clarence WilliamsJr.Jr., John W. Babich, Valery Radchenko & Justin J. Wilson. (2017) An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy. Angewandte Chemie International Edition 56:46, pages 14712-14717.
Crossref
Crossref
Nikki A. Thiele, Victoria Brown, James M. Kelly, Alejandro Amor‐Coarasa, Una Jermilova, Samantha N. MacMillan, Anastasia Nikolopoulou, Shashikanth Ponnala, Caterina F. Ramogida, Andrew K. H. Robertson, Cristina Rodríguez‐Rodríguez, Paul Schaffer, Clarence WilliamsJr.Jr., John W. Babich, Valery Radchenko & Justin J. Wilson. (2017) An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy. Angewandte Chemie 129:46, pages 14904-14909.
Crossref
Crossref
Christian Ekberg, Holger Jensen, Stephen P. Mezyk, Bruce J. Mincher & Gunnar Skarnemark. (2017) Extraction of 211At from nitric acid solutions into various organic solvents for use as an α-source for radiation chemistry studies. Journal of Radioanalytical and Nuclear Chemistry 314:1, pages 235-239.
Crossref
Crossref
Sarah-Maria Fendt. (2017) Is There a Therapeutic Window for Metabolism-Based Cancer Therapies?. Frontiers in Endocrinology 8.
Crossref
Crossref
Sandip Basu & Sharmila Banerjee. (2017) Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances. European Journal of Nuclear Medicine and Molecular Imaging 44:7, pages 1244-1246.
Crossref
Crossref
Giovanna Muggiolu, Michal Pomorski, Gérard Claverie, Guillaume Berthet, Christine Mer-Calfati, Samuel Saada, Guillaume Devès, Marina Simon, Hervé Seznec & Philippe Barberet. (2017) Single α-particle irradiation permits real-time visualization of RNF8 accumulation at DNA damaged sites. Scientific Reports 7:1.
Crossref
Crossref